Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.55 |
| ▸ | PRKCA | P17252 | 2/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.55 |
| ▸ | MAOA | P21397 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | SCN1A | P35498 | 2/20 | 0.48 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.48 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9721791 | 0.92 | PRKCA (0.61) | MAPTALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL828598 | 0.88 | PRKCA (0.68) | MAPTALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL30298672 | 0.87 | PRKCA (0.56) | MAPTALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL1959822 | 0.87 | PNLIP (0.59) | ALDH1A1LMNACYP1A2TSHRCYP2C19 | |
| SCHEMBL19380007 | 0.87 | LMNA (0.56) | MAPTALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL6429949 | 0.87 | PRKCA (0.56) | MAPTALDH1A1TSHRPRKCAPRKCD | |
| SCHEMBL6673103 | 0.86 | PNLIP (0.53) | MAPTALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL9068426 | 0.86 | LMNA (0.59) | MAPTALDH1A1NPC1RAB9ALMNA | |
| SCHEMBL9441341 | 0.85 | PNLIP (0.61) | ALDH1A1LMNACYP1A2TSHRCYP2C19 | |
| SCHEMBL22684929 | 0.85 | PNLIP (0.61) | ALDH1A1LMNACYP1A2TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104705-A2 | PROCESS FOR THE PRODUCTION OF C6-C18 ALKYL ESTERS OF 4-AMINOBENZOIC ACID | DSM IP ASSETS B.V. (NL) | 2026-05-21 | — | — | WO | claimed |
| WO-2026104705-A2 | PROCESS FOR THE PRODUCTION OF C6-C18 ALKYL ESTERS OF 4-AMINOBENZOIC ACID | DSM IP ASSETS B.V. (NL) | 2026-05-21 | — | — | WO | disclosed |
| WO-2020141081-A1 | PROCESS FOR SYNTHESIZING S-TRIAZINE COMPOUNDS | CLARIANT INTERNATIONAL LTD (CH) | 2020-07-09 | — | — | WO | disclosed |
| EP-3674293-A1 | PROCESS FOR SYNTHESIZING S-TRIAZINE COMPOUNDS | Clariant International Ltd (CH) | 2020-07-01 | — | — | EP | disclosed |
| EP-2688875-B1 | PROCESS FOR THE PREPARATION OF S-TRIAZINE COMPOUNDS | BASF SE (DE) | 2015-12-30 | — | — | EP | disclosed |
| US-9200171-B2 | AZO compound and ink containing the compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-12-01 | — | — | US | disclosed |
| US-8765753-B2 | Process for the preparation of s-triazine compounds | BASF SE (DE) | 2014-07-01 | — | — | US | disclosed |
| US-20140078577-A1 | AZO COMPOUND AND INK CONTAINING THE COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-03-20 | — | — | US | disclosed |
| EP-2688875-A1 | PROCESS FOR THE PREPARATION OF S-TRIAZINE COMPOUNDS | BASF SE (DE) | 2014-01-29 | — | — | EP | disclosed |
| US-20140005387-A1 | Process for the preparation of s-triazine compounds | BASF SE (DE) | 2014-01-02 | — | — | US | disclosed |
| WO-2012127425-A1 | PROCESS FOR THE PREPARATION OF S-TRIAZINE COMPOUNDS | BASF SE (DE) | 2012-09-27 | — | — | WO | disclosed |
| CN-1976675-A | Personal care composition comprising highly branched primary alcohol component | SHELL OIL CO (NL) | 2007-06-06 | — | — | CN | disclosed |
| US-20050196362-A1 | Personal care compositions containing highly branched primary alcohol component | SHELL OIL COMPANY | 2005-09-08 | — | — | US | disclosed |
| US-6153175-A | Indanylidene compounds, a process for their preparation and their use as UV absorbers | HAARMANN & REIMER GMBH (DE) | 2000-11-28 | — | — | US | disclosed |
| US-6037473-A | AS SUNSCREENS IN COSMETIC AND PHARMACEUTICAL PREPARATIONS; FOR ENHANCING PHOTOSTABILITY OF INDUSTRIAL PRODUCTS SUCH AS PAINTS, VARNISHES, PLASTICS, TEXTILES, PACKAGING MATERIALS AND RUBBERS | HAARMANN & REIMER GMBH (DE) | 2000-03-14 | — | — | US | disclosed |
| US-5965066-A | HIGH PROTECTION AGAINST BOTH UV-A AND UV-B RAYS AT LOW CONCENTRATIONS; RADIATION AND HEAT RESISTANCE; SUNSCREEN AGENTS; COSMETICS FOR SKIN AND HAIR | HAARMANN & REIMER GMBH (DE) | 1999-10-12 | — | — | US | disclosed |
| US-5961960-A | Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation | HAARMANN & REIMER GMBH (DE) | 1999-10-05 | — | — | US | disclosed |
| US-4724137-A | s-Triazine derivatives and their use as sun screen agents | BASF AKTIENGESELLSCHAFT (DE) | 1988-02-09 | — | — | US | disclosed |
| US-4617390-A | SUNSCREEN AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1986-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140005387-A1 | Process for the preparation of s-triazine compounds | TST, ADH1C, SPR | MAPT 3734/4885ALDH1A1 406/4885NPC1 4686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.